Oscar Health, Inc. (NYSE:OSCR – Get Free Report)’s stock price traded up 3.8% during mid-day trading on Tuesday . The stock traded as high as $16.53 and last traded at $16.47. 899,294 shares were traded during mid-day trading, a decline of 74% from the average session volume of 3,393,876 shares. The stock had previously closed at $15.87.
Analysts Set New Price Targets
Several equities analysts have commented on OSCR shares. Wells Fargo & Company raised their target price on shares of Oscar Health from $24.00 to $27.00 and gave the company an “overweight” rating in a research note on Wednesday, June 12th. Robert W. Baird initiated coverage on Oscar Health in a research note on Thursday, May 30th. They set an “outperform” rating and a $28.00 price objective for the company. The Goldman Sachs Group boosted their price target on shares of Oscar Health from $16.00 to $21.00 and gave the company a “neutral” rating in a report on Thursday, May 9th. Baird R W raised Oscar Health to a “strong-buy” rating in a research report on Thursday, May 30th. Finally, Piper Sandler initiated coverage on shares of Oscar Health in a research note on Wednesday, June 26th. They issued an “overweight” rating and a $25.00 price objective on the stock. Three research analysts have rated the stock with a hold rating, five have given a buy rating and one has given a strong buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $19.75.
Oscar Health Stock Up 4.5 %
The firm has a market capitalization of $3.94 billion, a price-to-earnings ratio of -40.05 and a beta of 1.62. The company has a debt-to-equity ratio of 0.29, a quick ratio of 1.10 and a current ratio of 1.10. The business’s 50 day moving average is $19.49 and its 200-day moving average is $15.48.
Oscar Health (NYSE:OSCR – Get Free Report) last issued its quarterly earnings results on Tuesday, May 7th. The company reported $0.62 EPS for the quarter, topping the consensus estimate of $0.28 by $0.34. Oscar Health had a negative return on equity of 5.77% and a negative net margin of 0.82%. The company had revenue of $2.14 billion for the quarter, compared to the consensus estimate of $1.99 billion. During the same period in the previous year, the business posted ($0.18) EPS. The company’s revenue for the quarter was up 45.8% on a year-over-year basis. Equities analysts anticipate that Oscar Health, Inc. will post -0.05 EPS for the current fiscal year.
Insider Activity at Oscar Health
In related news, COO Steven Wolin sold 18,607 shares of the stock in a transaction dated Monday, June 3rd. The shares were sold at an average price of $19.46, for a total value of $362,092.22. Following the completion of the sale, the chief operating officer now owns 65,316 shares in the company, valued at $1,271,049.36. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. In related news, COO Steven Wolin sold 18,607 shares of the company’s stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $19.46, for a total value of $362,092.22. Following the completion of the transaction, the chief operating officer now directly owns 65,316 shares in the company, valued at $1,271,049.36. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Mario Schlosser sold 5,808 shares of Oscar Health stock in a transaction on Monday, June 3rd. The stock was sold at an average price of $19.46, for a total transaction of $113,023.68. Following the sale, the insider now owns 65,920 shares in the company, valued at approximately $1,282,803.20. The disclosure for this sale can be found here. Insiders sold a total of 81,655 shares of company stock worth $1,589,006 in the last ninety days. 25.11% of the stock is currently owned by insiders.
Institutional Inflows and Outflows
Several hedge funds have recently added to or reduced their stakes in OSCR. Farallon Capital Management LLC bought a new stake in Oscar Health in the first quarter valued at $164,000. Beck Bode LLC acquired a new stake in shares of Oscar Health during the 1st quarter worth about $9,856,000. Bayesian Capital Management LP bought a new position in Oscar Health during the 1st quarter valued at about $1,066,000. First Light Asset Management LLC boosted its position in Oscar Health by 117.3% in the first quarter. First Light Asset Management LLC now owns 2,102,554 shares of the company’s stock valued at $31,265,000 after buying an additional 1,134,919 shares in the last quarter. Finally, Price T Rowe Associates Inc. MD boosted its position in Oscar Health by 153.5% in the first quarter. Price T Rowe Associates Inc. MD now owns 3,978,152 shares of the company’s stock valued at $59,156,000 after buying an additional 2,409,160 shares in the last quarter. Institutional investors and hedge funds own 75.70% of the company’s stock.
About Oscar Health
Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.